tiprankstipranks
Trending News
More News >
MaaT Pharma (FR:MAAT)
:MAAT
France Market

MaaT Pharma (MAAT) Technical Analysis

Compare
3 Followers

Summary of all the Indicators

Overall Consensus
Neutral
9Bullish
6Neutral
7Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
MaaT Pharma’s (MAAT) Moving Averages Convergence Divergence (MACD) indicator is -0.07, suggesting MaaT Pharma is a Sell.
MaaT Pharma’s (MAAT) 20-Day exponential moving average is 5.08, while MaaT Pharma’s (MAAT) share price is €5.24, making it a Buy.
MaaT Pharma’s (MAAT) 50-Day exponential moving average is 5.30, while MaaT Pharma’s (MAAT) share price is €5.24, making it a Sell.

MaaT Pharma (MAAT) Pivot Points

Jul 07, 2025, 02:01 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.00
4.50
4.90
5.40
5.80
6.30
6.70
Fibonacci
4.50
4.84
5.06
5.40
5.74
5.96
6.30
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

MaaT Pharma (MAAT) Moving Averages

Jul 07, 2025, 02:01 PM
Period
Simple
Exponential
MA5
5.00Buy
5.08Buy
MA10
4.96Buy
5.04Buy
MA20
5.11Buy
5.08Buy
MA50
5.22Buy
5.30Sell
MA100
5.73Sell
5.75Sell
MA200
6.72Sell
6.43Sell
MaaT Pharma’s (MAAT) 10-Day exponential moving average is 5.04, while MaaT Pharma’s (MAAT) share price is €5.24, making it a Buy.
MaaT Pharma’s (MAAT) 100-Day exponential moving average is 5.75, while MaaT Pharma’s (MAAT) share price is €5.24, making it a Sell.
MaaT Pharma’s (MAAT) stock price is €5.24 and MaaT Pharma’s (MAAT) 50-day simple moving average is 5.22, creating a Buy signal.
MaaT Pharma’s (MAAT) stock price is €5.24 and MaaT Pharma’s (MAAT) 100-day simple moving average is 5.73, creating a Sell signal.
MaaT Pharma’s (MAAT) stock price is €5.24 and MaaT Pharma’s (MAAT) 200-day simple moving average is 6.72, creating a Sell signal.

MaaT Pharma (MAAT) Technical Indicators

Jul 07, 2025, 02:01 PM
Name
Value
Implied Action
RSI (14)
53.49
Neutral
STOCH (9,6)
34.35
Neutral
STOCHRSI (14)
33.31
Neutral
MACD (12,26)
-0.07
Sell
ADX (14)
21.42
Neutral
Williams %R
-56.90
Buy
CCI (14)
38.32
Neutral
ATR (14)
0.33
-
Ultimate Oscillator
37.20
Neutral
ROC
-1.87
Sell
MaaT Pharma’s (MAAT) Relative Strength Index (RSI) is 53.49, creating a Neutral signal.
MaaT Pharma’s (MAAT) Trend Strength Indicator (ADX) is 21.42, creating a Neutral signal.
MaaT Pharma’s (MAAT) Commodity Channel Index (CCI) is 38.32, creating a Neutral signal.
MaaT Pharma’s (MAAT) Price Rate of Change (ROC) is -1.87, creating a Sell signal.

FAQ

Is MAAT a Buy, Hold, or Sell?
Based on MAAT’s technical indicators, MAAT is a Hold.
    What is MAAT’s RSI (14)?
    MAAT’s RSI (14) is 53.49, which suggests MAAT is a Neutral.
      What is MAAT’s MACD?
      MAAT’s MACD is -0.07, which suggests MAAT is a Sell.
        What is MAAT’s 5-day moving average?
        MAAT’s 5-day moving average is 5.00, which suggests MAAT is a Buy.
          What is MAAT’s 20-day moving average?
          MAAT 20-day moving average is 5.11, which suggests MAAT is a Buy.
            What is MAAT’s 50-day moving average?
            MAAT’s 50-day moving average is 5.22, which suggests MAAT is a Buy.
              What is MAAT’s 200-day moving average?
              MAAT’s 200-day moving average is 6.72, which suggests MAAT is a Sell.
                What is MAAT’s Williams % R (14)?
                MAAT’s Williams % R (14) is -56.90, which suggests MAAT is a Buy.
                  What is MAAT’s CCI (14)?
                  MAAT’s CCI (14) is 38.32, which suggests MAAT is a Neutral.
                    What is the share price of MaaT Pharma?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis